Bicara Therapeutics Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BCAX

organization

SIC: 2834

SEC Insider

$88.7M

244 transactions

Summary

Bicara Therapeutics Inc. (BCAX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $74.3MSales: $11.4M32 insiders

Date	Insider	Type	Value
2026-05-18	Mazumdar Claire(Chief Executive Officer)	Sell	$240K
2026-05-21	Hyep Ivan(Chief Financial Officer)	Sell	$188K
2026-05-15	Cohlhepp Ryan(President and COO)	Sell	$162K
2026-05-15	Cohlhepp Ryan(President and COO)	Sell	$91K
2026-05-18	Mazumdar Claire(Chief Executive Officer)	Sell	$61K
2026-05-18	Mazumdar Claire(Chief Executive Officer)	M	$57K
2026-05-21	Hyep Ivan(Chief Financial Officer)	M	$35K
2026-05-15	Cohlhepp Ryan(President and COO)	M	$30K
2026-06-09	Joint reporting: RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.; RA Capital Nexus Fund III, L.P.	A	$0
2026-06-09	Simson Jake	A	$0
2026-06-09	POWELL MICHAEL	A	$0
2026-06-09	Robertson Scott M.	A	$0
2026-06-09	Mazumdar-Shaw Kiran	A	$0
2026-06-09	Haviland Kate	A	$0
2026-06-09	Bowden Christopher	A	$0
2026-05-21	Hyep Ivan(Chief Financial Officer)	M	$0
2026-05-18	Mazumdar Claire(Chief Executive Officer)	M	$0
2026-05-15	Cohlhepp Ryan(President and COO)	M	$0
2026-05-08	Schelman William(Chief Medical Officer)	A	$0
2026-04-27	Raben David(Chief Medical Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Bicara Therapeutics Inc. — Contributions, Lobbying & Contracts | Poliscope